If you are not happy with the results below please do another search
LGC has acquired The Native Antigen Company (NAC), one of the world’s leading suppliers of high quality infectious disease antigens and antibodies. NAC is a developer, manufacturer and supplier of critical reagents to the in vitro diagnostic (IVD), pharmaceutical and academic sectors. It offers a comprehensive portfolio of native and recombinant infectious disease antigens and […]
The advent of molecular biology techniques has revolutionized disease diagnosis. CLI discussed with Dr Chandrasekhar Nair from Molbio Diagnostics the benefit that these techniques have brought and how these technologies are being adapted for point-of-care use for rapid diagnosis and the benefit of rural populations. What has the impact of molecular biology been on disease […]
OXGENE and The Native Antigen Company are collaborating to scale up production of SARS-CoV-2 reagents by combining OXGENE’s proprietary Adenoviral Protein Machine Technology with The Native Antigen Company’s antigen development expertise. Together, they aim to scale their antigen manufacturing capabilities to deliver high-purity, recombinant proteins for the development of diagnostics and vaccines. Unlike the PCR […]
Expert opinions from Dr Heidi Mendoza There are many assessments to make when adding a new test to a lab’s collection. Dr Heidi Mendoza, acting consultant clinical biochemist at Raigmore Hospital, Inverness, UK, shares her experiences and observations of doing exactly that in both ordinary circumstances and during a pandemic, as well as having to […]
Labs working to combat Covid-19 will benefit from this initiative, as CytoSMART aims to reduce the huge workload currently facing researchers on projects vital to controlling the disease. CytoSMART’s unique and compact live-cell microscope films living cell cultures without disturbing their growth or behaviour. The device operates from inside cell culture incubators and is accessible […]
UK-based PCR Biosystems issued a statement 1 April saying they are continuing to scale up operations to ensure the critical enzyme mix for COVID-19 tests remain available to the UK and global healthcare systems as demand for testing rises. To meet current and upcoming requirements and ensure supply chain security, PCR Biosystems has already significantly […]
During the course of the current coronavirus pandemic we have all been aware of the urgent need for nucleic acid testing to identify people currently infected with SARS-CoV-2. The second test that is needed, the serology test, to identify who has had the virus, is much more complex to produce. Dr Andy Lane, commercial director […]
As the COVID-19 pandemic progresses in countries around the globe, there is an urgent need for rapid and reliable point-of-need detection testing. Dolomite Microfluidics and Mologic are working together to accelerate the development and launch of these tests. UK-based Mologic is a leading developer of rapid response diagnostic tests for diseases such as malaria and […]
As COVID-19 multiplied across the globe in early 2020, IVD companies raced to provide testing solutions. However, rapid development of diagnostic solutions led in some cases to compromised reagent quality, causing confusion and concern amongst clinicians and lab professionals. With this background, Erba Mannheim committed to develop reliable and affordable solutions to SARS-CoV-2 testing. First […]
NovaTec is excited to collaborate in the fight against COVID-19 providing reliable direct pathogen and antibody detection assays to aid in the diagnosis of SARS-CoV-2. These tests are CE-IVD marked and immediately available. The development of the assays has been spearheaded by affiliate companies Gold Standard Diagnostics Inc., NovaTec Immundiagnostica GmbH, and VIROTECH Diagnostics GmbH. […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
